SAN FRANCISCO--(BUSINESS WIRE)--Urigen Pharmaceuticals, Inc. (OTC BB:URGP) (http://www.urigen.com), a specialty pharmaceutical company focused on the development and commercialization of treatments for urological disorders, announced today that a discussion on Interstitial Cystitis is scheduled to be the topic of today’s episode of The Doctors, a popular daily television program that offers expert healthcare advice. Urigen’s URG101, a proprietary combination of approved drugs that is instilled into the bladder, targets painful bladder syndrome, which afflicts approximately 10.5 million men and women in North America.
